Logo image of TOUR

TUNIU CORP-SPON ADR (TOUR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TOUR - US89977P1066 - ADR

0.725 USD
-0.01 (-0.68%)
Last: 12/2/2025, 8:11:22 PM
Fundamental Rating

3

Overall TOUR gets a fundamental rating of 3 out of 10. We evaluated TOUR against 132 industry peers in the Hotels, Restaurants & Leisure industry. TOUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TOUR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year TOUR was profitable.
TOUR had negative earnings in 4 of the past 5 years.
In multiple years TOUR reported negative operating cash flow during the last 5 years.
TOUR Yearly Net Income VS EBIT VS OCF VS FCFTOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

TOUR has a Return On Assets (1.64%) which is in line with its industry peers.
The Return On Equity of TOUR (2.92%) is comparable to the rest of the industry.
The Return On Invested Capital of TOUR (2.29%) is worse than 68.18% of its industry peers.
Industry RankSector Rank
ROA 1.64%
ROE 2.92%
ROIC 2.29%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
TOUR Yearly ROA, ROE, ROICTOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

TOUR has a Profit Margin (5.59%) which is comparable to the rest of the industry.
With a Operating Margin value of 5.19%, TOUR is not doing good in the industry: 62.88% of the companies in the same industry are doing better.
TOUR has a Gross Margin of 64.21%. This is in the better half of the industry: TOUR outperforms 79.55% of its industry peers.
TOUR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.19%
PM (TTM) 5.59%
GM 64.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
TOUR Yearly Profit, Operating, Gross MarginsTOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TOUR is destroying value.
TOUR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TOUR has been reduced compared to 5 years ago.
The debt/assets ratio for TOUR has been reduced compared to a year ago.
TOUR Yearly Shares OutstandingTOUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOUR Yearly Total Debt VS Total AssetsTOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -4.94, we must say that TOUR is in the distress zone and has some risk of bankruptcy.
TOUR has a Altman-Z score of -4.94. This is amonst the worse of the industry: TOUR underperforms 93.18% of its industry peers.
TOUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
TOUR has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. TOUR outperforms 90.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.94
ROIC/WACC0.25
WACC9.31%
TOUR Yearly LT Debt VS Equity VS FCFTOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

TOUR has a Current Ratio of 1.63. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
TOUR has a Current ratio of 1.63. This is in the better half of the industry: TOUR outperforms 75.76% of its industry peers.
TOUR has a Quick Ratio of 1.63. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.63, TOUR is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63
TOUR Yearly Current Assets VS Current LiabilitesTOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 188.89% over the past year.
TOUR shows a small growth in Revenue. In the last year, the Revenue has grown by 7.71%.
TOUR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -25.77% yearly.
EPS 1Y (TTM)188.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)7.71%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%15.53%

3.2 Future

Based on estimates for the next years, TOUR will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.57% on average per year.
The Revenue is expected to grow by 9.88% on average over the next years. This is quite good.
EPS Next Y-84.34%
EPS Next 2Y-48.52%
EPS Next 3Y-29.57%
EPS Next 5YN/A
Revenue Next Year8.66%
Revenue Next 2Y9.42%
Revenue Next 3Y9.88%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TOUR Yearly Revenue VS EstimatesTOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
TOUR Yearly EPS VS EstimatesTOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 2025 2026 2027 0 -5 -10 -15

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.17, TOUR is valued on the expensive side.
TOUR's Price/Earnings ratio is a bit cheaper when compared to the industry. TOUR is cheaper than 60.61% of the companies in the same industry.
When comparing the Price/Earnings ratio of TOUR to the average of the S&P500 Index (26.15), we can say TOUR is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 22.85, the valuation of TOUR can be described as rather expensive.
TOUR's Price/Forward Earnings ratio is in line with the industry average.
TOUR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.22, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.17
Fwd PE 22.85
TOUR Price Earnings VS Forward Price EarningsTOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOUR is valued a bit more expensive than the industry average as 61.36% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.83
TOUR Per share dataTOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as TOUR's earnings are expected to decrease with -29.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.52%
EPS Next 3Y-29.57%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.05%, TOUR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.72, TOUR pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, TOUR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

TOUR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TOUR Yearly Dividends per shareTOUR Yearly Dividends per shareYearly Dividends per share 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-48.52%
EPS Next 3Y-29.57%
TOUR Yearly Income VS Free CF VS DividendTOUR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

TUNIU CORP-SPON ADR

NASDAQ:TOUR (12/2/2025, 8:11:22 PM)

0.725

-0.01 (-0.68%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-15 2025-08-15/bmo
Earnings (Next)12-05 2025-12-05/bmo
Inst Owners8.84%
Inst Owner Change-9.96%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap85.34M
Revenue(TTM)542.00M
Net Income(TTM)30.30M
Analysts85.71
Price Target1.73 (138.62%)
Short Float %0.4%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27 2025-03-27 (0.036)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)62.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.03%
Valuation
Industry RankSector Rank
PE 24.17
Fwd PE 22.85
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.59
EV/EBITDA 15.83
EPS(TTM)0.03
EY4.14%
EPS(NY)0.03
Fwd EY4.38%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.65
BVpS1.25
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.92
Profitability
Industry RankSector Rank
ROA 1.64%
ROE 2.92%
ROCE 2.89%
ROIC 2.29%
ROICexc 2.29%
ROICexgc 2.34%
OM 5.19%
PM (TTM) 5.59%
GM 64.21%
FCFM N/A
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
F-ScoreN/A
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z -4.94
F-ScoreN/A
WACC9.31%
ROIC/WACC0.25
Cap/Depr(3y)62.83%
Cap/Depr(5y)47.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)188.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-84.34%
EPS Next 2Y-48.52%
EPS Next 3Y-29.57%
EPS Next 5YN/A
Revenue 1Y (TTM)7.71%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%15.53%
Revenue Next Year8.66%
Revenue Next 2Y9.42%
Revenue Next 3Y9.88%
Revenue Next 5YN/A
EBIT growth 1Y-59.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year607.1%
EBIT Next 3Y117.6%
EBIT Next 5YN/A
FCF growth 1Y-62.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.8%
OCF growth 3YN/A
OCF growth 5YN/A

TUNIU CORP-SPON ADR / TOUR FAQ

What is the ChartMill fundamental rating of TUNIU CORP-SPON ADR (TOUR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TOUR.


What is the valuation status of TUNIU CORP-SPON ADR (TOUR) stock?

ChartMill assigns a valuation rating of 2 / 10 to TUNIU CORP-SPON ADR (TOUR). This can be considered as Overvalued.


How profitable is TUNIU CORP-SPON ADR (TOUR) stock?

TUNIU CORP-SPON ADR (TOUR) has a profitability rating of 2 / 10.


What are the PE and PB ratios of TUNIU CORP-SPON ADR (TOUR) stock?

The Price/Earnings (PE) ratio for TUNIU CORP-SPON ADR (TOUR) is 24.17 and the Price/Book (PB) ratio is 0.58.